Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA

K-Number: K190397 · 2019-11-15

Decision Date2019-11-15
Product CodeQBK
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is a medical device manufactured by Immunalysis Corporation. It received FDA 510(k) clearance on 2019-11-15 under approval number K190397. The device is classified under product code QBK. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is a medical device that received FDA 510(k) clearance on 2019-11-15. It is manufactured by Immunalysis Corporation. The 510(k) number is K190397.

When was Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA approved by the FDA?

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA received FDA 510(k) clearance on 2019-11-15, under approval number K190397.

What company makes Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is manufactured by Immunalysis Corporation.

What is the FDA product code for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?

The FDA product code for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is QBK.

Other Devices by Immunalysis Corporation

View all 15 devices →

Related Devices (Code: QBK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.